Back to Authors

Curiel, Tyler Jay

0000-0001-6962-9411

A5074770263 | I165951966

Mayo Clinic

The University of Texas at San Antonio Health Science Center

Citations 1

Safety and efficacy of durvalumab (MEDI4736), a PD-L1 antibody, in urothelial bladder cancer.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4502-4502

10.1200/jco.2016.34.15_suppl.4502